The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Open accessAbstract
SUMMARY Rhabdomyosarcoma is a soft-tissue sarcoma with molecular and cellular features of developing skeletal muscle. Rhabdomyosarcoma has two major histological subtypes, embryonal and alveolar, each with distinct clinical, molecular, and genetic features. Genomic analysis show that embryonal tumors have more structural and copy number variations than alveolar tumors. Mutations in the RAS/NF1 pathway are significantly associated with intermediate- and high-risk embryonal rhabdomyosarcomas (ERMS). In contrast, alveolar rhabdomyosarcoma (ARMS) have fewer genetic lesions overall and no known recurrently mutated cancer consensus genes. To identify therapeutics for ERMS, we developed and characterized orthotopic xenografts of tumors that were sequenced in our study. High throughput screening of primary cultures derived from those xenografts identified oxidative stress as a pathway of therapeutic relevance for ERMS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Dasmahapatra, G. P., Lembersky, D., Kramer, L. B., Fisher, R. I., Friedberg, J. W., Dent, P., & Grant, S. (2010) · Blood · doi:10.1182/blood-2009-12-257261 · Cited by 115
RetractedDasmahapatra, G. P., Lembersky, D., Son, M. P., Attkisson, E., Dent, P., Fisher, R. I., Friedberg, J. W., & Grant, S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1108 · Cited by 62
RetractedDasmahapatra, G. P., Almenara, J. A., & Grant, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016154 · Cited by 40
RetractedNowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · cited 1×
“SVs and CNVs can be caused by the gradual, progressive accumulation of chromosomal and regional lesions during each round of cell division, or they may be caused by a single acute event such as chromothripsis (Stephens et al., 2011).”
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · cited 2×
“%) was higher than that found in T cell acute lymphoblastic leukemia (T-ALL) and medulloblastoma (MB) (T-ALL + MB, 17.8%; p = 0.0003) (Robinson et al., 2012; Zhang et al., 2012) but lower than that found in lung cancer (32.7%; p = 0.00014) (Cancer GenomeAtlas Network, 2012).”
InfluentialSelf-citationIntergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
Crist, W. M., Anderson, J. R., Meza, J. L., Fryer, C., Raney, R. B., Ruymann, F. B., Breneman, J., Qualman, S. J., Wiener, E., Wharam, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3091 · Cited by 1,087
Novel mutations target distinct subgroups of medulloblastoma
Robinson, G., Parker, M., Kranenburg, T. A., Lu, C., Chen, X., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 846
Self-citationButler, L. M., Zhou, X., Xu, W.-S., Scher, H. I., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182372299 · Cited by 510
Williamson, D., Missiaglia, E., de Reyniès, A., Pierron, G., Thuille, B., Palenzuela, G., Thway, K., Orbach, D., Laé, M., Fréneaux, P., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3814 · Cited by 502
Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005
Ognjanovic, S., Linabery, A. M., Charbonneau, B., & Ross, J. A. (2009) · Cancer · doi:10.1002/cncr.24465 · Cited by 497
MICU1 Controls Both the Threshold and Cooperative Activation of the Mitochondrial Ca2+ Uniporter
Csordás, G., Golenár, T., Seifert, E. L., Kamer, K. J., Sancak, Y., Perocchi, F., Moffat, C., Weaver, D., Perez, S. D. L. F., Bogorad, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.020 · Cited by 490
Malempati, S., & Hawkins, D. S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24118 · Cited by 422
Self-citationRare cancer-specific mutations in PIK3CA show gain of function
Gymnopoulos, M., Elsliger, M.-A., & Vogt, P. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701005104 · Cited by 376
Raney, R. B., Anderson, J. R., Barr, F. G., Donaldson, S. S., Pappo, A. S., Qualman, S. J., Wiener, E. S., Maurer, H. M., & Crist, W. M. (2001) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200105000-00008 · Cited by 376
Self-citationTherapeutic Strategies for Targeting Ras Proteins
Gysin, S., Salt, M., Young, A., & McCormick, F. (2011) · Genes & Cancer · doi:10.1177/1947601911412376 · Cited by 323
Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A., & Capecchi, M. R. (2004) · Genes & Development · doi:10.1101/gad.1244004 · Cited by 304
Hutcheson, D. A., Zhao, J., Merrell, A., Haldar, M., & Kardon, G. (2009) · Genes & Development · doi:10.1101/gad.1769009 · Cited by 301
Aiding and abetting roles of NOX oxidases in cellular transformation
Block, K., & Gorin, Y. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3339 · Cited by 297
Pappo, A. S., Anderson, J. R., Crist, W. M., Wharam, M. D., Breitfeld, P. P., Hawkins, D., Raney, R. B., Womer, R. B., Parham, D. M., Qualman, S. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3487 · Cited by 275
Self-citationNewton, W. A., Soule, E. H., Hamoudi, A. B., Reiman, H. M., Shimada, H., Beltangady, M., & Maurer, H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.67 · Cited by 267
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting.
Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., & Sapienza, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7480 · Cited by 261
Bouitbir, J., Charles, A.-L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., Piquard, F., Geny, B., & Zoll, J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr224 · Cited by 256 · cited 1×
“However, it has been shown that this effect is cell-type specific and in skeletal muscle, statins can have the opposite effect and increase oxidative stress contributing to rhabdomyolysis, amajor side effect of statins (Bouitbir et al., 2012).”
Gibbs, C. P., Weber, K., & Scarborough, M. T. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200111000-00019 · Cited by 235
Shukla, N., Ameur, N., Yilmaz, I., Nafa, K., Lau, C.-Y., Marchetti, A., Borsu, L., Barr, F. G., & Ladanyi, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2056 · Cited by 232
Rubin, B. P., Nishijo, K., Chen, H.-I. H., Yi, X., Schuetze, D. P., Pal, R., Prajapati, S. I., Abraham, J., Arenkiel, B. R., Chen, Q.-R., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.023 · Cited by 190
Skalli, O., Gabbiani, G., Babaï, F., Seemayer, T. A., Pizzolato, G. P., & Schürch, W. (1988) · PubMed · Cited by 187
Stratton, M. R., Fisher, C., Gusterson, B. A., & Cooper, C. S. (1989) · PubMed · Cited by 168
Muscling in: Uncovering the origins of rhabdomyosarcoma
Hettmer, S., & Wagers, A. J. (2010) · Nature Medicine · doi:10.1038/nm0210-171 · Cited by 151
Minai, L., Yeheskely‐Hayon, D., & Yelin, D. (2013) · Scientific Reports · doi:10.1038/srep02146 · Cited by 148
Paulson, V., Chandler, G. L., Rakheja, D., Galindo, R. L., Wilson, K., Amatruda, J. F., & Cameron, S. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20864 · Cited by 129
RAS signaling dysregulation in human embryonal Rhabdomyosarcoma
Martinelli, S., McDowell, H. P., Vigne, S. D., Kokai, G. K., Uccini, S., Tartaglia, M., & Dominici, C. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20702 · Cited by 119
Tian, J., Liu, J., Garlid, K., Shapiro, J. I., & Xie, Z. (2003) · Springer eBooks · doi:10.1007/978-1-4757-4712-6_23 · Cited by 90
Davicioni, E., Anderson, J. R., Buckley, J. D., Meyer, W. H., & Triche, T. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1268 · Cited by 90
Tian, J., Liu, J., Garlid, K., Shapiro, J. I., & Xie, Z. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1021114501561 · Cited by 69
Integrated cross-species transcriptional network analysis of metastatic susceptibility
Hu, Y., Wu, G., Rusch, M., Lukes, L., Buetow, K. H., Zhang, J., & Hunter, K. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117872109 · Cited by 59
Self-citationRecent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents
Liu, Y., Li, Y., Yu, S., & Zhao, G. (2012) · Current Drug Targets · doi:10.2174/138945012803530224 · Cited by 55
Huang, J.-M., Sheard, M. A., Ji, L., Sposto, R., & Keshelava, N. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0562 · Cited by 49
Chromosomal translocations involving paired box transcription factors in human cancer
Barr, F. G. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00095-2 · Cited by 36
Tsuruga, M., Dang, Y., Shiono, Y., Oka, S., & Yamazaki, Y. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024912806686 · Cited by 15
Cited by
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Self-citationSkapek, S. X., Ferrari, A., Gupta, A. A., Lupo, P. J., Butler, E., Shipley, J., Barr, F. G., & Hawkins, D. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0051-2 · Cited by 875
Self-citationRecurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752
Self-citationTirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
Self-citationThe Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
Brohl, A. S., Solomon, D. A., Chang, W., Wang, J., Song, Y., Sindiri, S., Patidar, R., Hurd, L., Chen, L., Shern, J. F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004475 · Cited by 435
Self-citation
Metadata
- Authors
- Chen, X., Stewart, E., Shelat, A. A., Qu, C., Bahrami, A., Hatley, M., Wu, G., Bradley, C., McEvoy, J., Pappo, A., Spunt, S., Valentine, M. B., Valentine, V., Krafcik, F., Lang, W. H., Wierdl, M., Tsurkan, L., Tolleman, V., Federico, S. M., Morton, C., Lu, C., Ding, L., Easton, J., Rusch, M., Nagahawatte, P., Wang, J., Parker, M., Wei, L., Hedlund, E., Finkelstein, D., Edmonson, M., Shurtleff, S., Boggs, K., Mulder, H., Yergeau, D., Skapek, S., Hawkins, D. S., Ramirez, N., Potter, P. M., Sandoval, J. A., Davidoff, A. M., Mardis, E. R., Wilson, R. K., Zhang, J., Downing, J. R., & Dyer, M. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 24
- Issue
- 6
- Pages
- 710-724
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2062972691
- Cited by
- 294
- References
- 43
- FWCI
- 17.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.